Private Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92K Buy
3,822
+2,018
+112% +$52.8K 0.02% 175
2026
Q1
$50.6K Sell
1,804
-1,666
-48% -$44.4K 0.01% 193
2025
Q4
$86.4K Buy
3,470
+24
+0.7% +$605 0.02% 139
2025
Q3
$87.8K Buy
3,446
+261
+8% +$6.44K 0.02% 135
2025
Q2
$77.2K Sell
3,185
-72
-2% -$1.68K 0.03% 132
2025
Q1
$82.5K Buy
3,257
+378
+13% +$9.89K 0.03% 125
2024
Q4
$76.4K Sell
2,879
-558
-16% -$15.1K 0.03% 137
2024
Q3
$99.5K Buy
3,437
+92
+3% +$2.68K 0.04% 105
2024
Q2
$93.6K Sell
3,345
-318
-9% -$8.76K 0.04% 109
2024
Q1
$102K Buy
3,663
+274
+8% +$7.6K 0.05% 98
2023
Q4
$97.6K Buy
+3,389
New +$102K 0.05% 101

Other funds holding PFE

Private Wealth Management Group's PFE Position: Q2 2026 in Review

Private Wealth Management Group increased its Pfizer (PFE) stake by 112% in Q2 2026, buying an estimated $52.8K and bringing the position to 3,822 shares worth $92K. The position accounts for 0.02% of the portfolio, ranked #175.

Private Wealth Management Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $102K in Q1 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Private Wealth Management Group held 3,822 shares of Pfizer worth $92K as of Q2 2026.
  • Private Wealth Management Group bought 2,018 Pfizer shares in Q2 2026, an estimated $52.8K.
  • Pfizer made up 0.02% of Private Wealth Management Group's portfolio in Q2 2026, its #175 holding.
  • Private Wealth Management Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Pfizer position peaked at $102K in Q1 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.